JNC CardioConnect

Episode 5: JNC Compendium: F-18 Flurpiridaz PET Myocardial Perfusion Imaging with Panithaya Chareonthaitawee, MD, Krishna Patel, MD, MS, FASNC, and Rob S.B. Beanlands, MD, MASNC

In this episode, Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, is joined by leading experts Panithaya Chareonthaitawee, MD, from the Mayo Clinic, Krishna Patel, MD, MS, FASNC, from the Icahn School of Medicine at Mount Sinai, along with Rob S.B. Beanlands, MD, MASNC, from the University of Ottawa Heart Institute, to discuss the JNC Compendium on Flurpiridaz PET Myocardial Perfusion Imaging. This episode dives deep into the transformative changes in radionuclide myocardial perfusion imaging and the potential role of flurpiridaz PET in this evolution. Discover the potential benefits of flurpiridaz for improving access to cardiac PET and expanding its clinical use. Our expert guests share insights on the many opportunities and offer their thoughts on how to tackle potential challenges. Do not miss it! Read the Compendium

Current practices and trends in amyloidosis imaging with bone-avid tracer cardiac scintigraphy with Jamieson M. Bourque, MD, MHS, FASNC, Sarah AM. Cuddy, MD, FASNC, and Nishant Shah, MD, MPH, FASNC

In this episode, Editor-in-Chief Marcelo F. Di Carli, MD, MASNC is joined by leading experts Jamieson M. Bourque, MD, MHS, FASNC from the University of Virginia and Sarah AM. Cuddy, MD, FASNC from the Brigham and Women’s Hospital along with Associate Editor, Nishant Shah, MD, FASNC, from the Brown University Alpert Medical School to discuss the evolving role of imaging in diagnosing cardiac amyloidosis.
The conversation focuses on a recent JNC paper analyzing survey data from ASNC on the adoption of radionuclide imaging for ATTR cardiac amyloidosis. The conversation highlights key findings, including shifts in imaging protocols, the growing role of nuclear medicine specialists, and the need for continuous education to ensure high-quality diagnostic standards.
They also discuss the future of the field, including the transition to SPECT/CT, potential PET applications, and the importance of national registries to track clinical outcomes. Read the article.

Episode 3: Effect of Imaging Timing on the Assessment of Treatment Response in Cardiac Sarcoidosis with Chaitanya Rojulpote, MD, Paco E. Bravo, MD, and Sanjay Divakaran, MD, FASNC

In the third episode of JNC CardioConnect, Journal of Nuclear Cardiology (JNC) Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, speaks with Chaitanya Rojulpote, MD and Paco E. Bravo, MD from the Hospital of the University of Pennsylvania, along with Associate Editor, Sanjay Divakaran, MD, FASNC, from the Brigham and Women's Hospital about the article, Assessing the effect of repeat positron emission tomography imaging on treatment response and cardiovascular outcomes among a homogenously treated cohort of patients with suspected cardiac sarcoidosis, published recently in the JNC.

Episode 2: The Changing Landscape of Cardiac Imaging

Radionuclide perfusion imaging remains the dominant force in coronary artery disease assessment, with SPECT leading the charge and PET on a steady rise. In this episode of JNC CardioConnect, Journal of Nuclear Cardiology (JNC) Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, speaks with physicians at Houston Methodist Hospital to discuss their recent article and break down the latest Medicare data, highlighting usage trends in cardiac imaging, underutilized opportunities with PET/CT and myocardial blood flow, and what it all means for the future of cardiac imaging.

Episode 1: Role of Quantitative Radionuclide Imaging in Cardiac Amyloidosis

In this episode of JNC CardioConnect, Journal of Nuclear Cardiology (JNC) Editor-in-Chief Marcelo F. Di Carli, MD, MASNC, speaks with Sharmila Dorbala, MD, MPH, MASNC, Director of Nuclear Cardiology at the Brigham and Women's Hospital and Professor of Radiology and Medicine at Harvard Medical School, about the article, Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy, published recently in the JNC, and her extensive research in cardiac amyloidosis.